By Jimmy Hoover ( April 7, 2016, 5:19 PM EDT) -- Genzyme Therapeutic Products urged a Federal Circuit panel Thursday to reverse a Patent Trial and Appeal Board decision gutting its two patents covering methods of treating a muscle disease, insisting the board's final decision relied on new arguments Genzyme wasn't given time to respond to....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.